Back to Search Start Over

Determination of the glycosylation-pattern of the middle ear mucosa in guinea pigs

Authors :
Engleder, Elisabeth
Demmerer, Elisabeth
Wang, Xueyan
Honeder, Clemens
Zhu, Chengjing
Studenik, Christian
Wirth, Michael
Arnoldner, Christoph
Gabor, Franz
Source :
International Journal of Pharmaceutics. 484(1-2):124-130
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Abstract

In the present study the glycosylation pattern of the middle ear mucosa (MEM) of guinea pigs, an approved model for middle ear research, was characterized with the purpose to identify bioadhesive ligands which might prolong the contact time of drug delivery systems with the middle ear mucosa (MEM). To assess the utility of five fluorescein labeled plant lectins with different carbohydrate specificities as bioadhesive ligands, viable MEM specimens were incubated at 4°C and the lectin binding capacities were calculated from the MEM-associated relative fluorescence intensities. Among all lectins under investigation, fluorescein-labeled wheat germ agglutinin (F-WGA) emerged as the highest bioadhesive lectin. In general, the accessibility of carbohydrate moieties of the MEM followed the order: sialic acid and N-acetyl-d-glucosamine (WGA)>>mannose and galactosamine (Lens culinaris agglutinin)>N-acetyl-d-glucosamine (Solanum tuberosum agglutinin)>fucose (Ulex europaeus isoagglutinin I)>>terminal mannose α-(1,3)-mannose (Galanthus nivalis agglutinin). Competitive inhibition studies with the corresponding carbohydrate revealed that F-WGA-binding was inhibited up to 90% confirming specificity of the F-WGA–MEM interaction. The cilia of the MEM were identified as F-WGA binding sites by fluorescence imaging as well as a z-stack of overlays of transmission, F-WGA- and nuclei-stained images of the MEM. Additionally, co-localisation experiments revealed that F-WGA bound to acidic mucopolysaccharides of the MEM. All in all, lectin-mediated bioadhesion to the MEM is proposed as a new concept for drug delivery to prolong the residence time of the drug in the tympanic cavity especially for successful therapy for difficult-to-treat diseases such as otitis media.

Details

ISSN :
03785173
Volume :
484
Issue :
1-2
Database :
OpenAIRE
Journal :
International Journal of Pharmaceutics
Accession number :
edsair.dedup.wf.001..a987da29003b8691d0117d1210d79206
Full Text :
https://doi.org/10.1016/j.ijpharm.2015.02.056